Table 1B Immunocompromised characteristics and viral loads

Intercept

-

-

20.829

[20.593;21.066]

< 0.001

Solid organ transplant

181 (28.2)

20.5

[18.0–23.0]

-0.186

[-0.523;0.152]

-

Autoimmune or inflammatory diseases

133 (20.7)

21.0

[18.6–23.0]

-

-

-

Oncology

116 (18.1)

19.4

[16.6–21.6]

-1.372

[-1.713;-1.031]

< 0.001

Hemato-oncology

82 (12.8)

21.9

[19.1–24.1]

0.743

[0.351;1.136]

-

HIV infection

50 (7.8)

20.1

[18.0–23.0]

0.242

[-0.769;0.285]

-

Anti-CD20 treatment including Rituximab

44 (6.9)

20.8

[18.0-22.3]

0.434

[-0.876;0.008]

-

Intensive care

18 (2.8)

20.2

[18.6–21.8]

0.3

[-0.875;0.276]

-

Respiratory diseases

17 (2.7)

20.5

[18.0–23.0]

-0.163

[-1.007;0.681]

-